OTCMKTS:BTCY Biotricity (BTCY) Stock Price, News & Analysis $0.25 -0.03 (-10.71%) (As of 09/27/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Biotricity alerts: Email Address About Biotricity Stock (OTCMKTS:BTCY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Biotricity alerts:Sign Up Key Stats Today's Range$0.24▼$0.3050-Day Range$0.28▼$0.8452-Week Range$0.24▼$2.22Volume66,387 shsAverage Volume75,328 shsMarket Capitalization$5.41 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Read More… Jovine Was Right in 2008—Will You Listen This Time? (Ad)The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.Take these 4 steps today to protect your retirement NOW Biotricity Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks11th Percentile Overall ScoreBTCY MarketRank™: Biotricity scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Biotricity.Read more about Biotricity's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Biotricity is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Biotricity is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.05% of the outstanding shares of Biotricity have been sold short.Short Interest Ratio / Days to CoverBiotricity has a short interest ratio ("days to cover") of 5.6.Change versus previous monthShort interest in Biotricity has recently decreased by 21.75%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBiotricity does not currently pay a dividend.Dividend GrowthBiotricity does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.05% of the outstanding shares of Biotricity have been sold short.Short Interest Ratio / Days to CoverBiotricity has a short interest ratio ("days to cover") of 5.6.Change versus previous monthShort interest in Biotricity has recently decreased by 21.75%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News SentimentN/A News SentimentBiotricity has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Biotricity this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for BTCY on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Biotricity insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.98% of the stock of Biotricity is held by insiders.Percentage Held by InstitutionsOnly 3.89% of the stock of Biotricity is held by institutions.Read more about Biotricity's insider trading history. Receive BTCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. Email Address BTCY Stock News HeadlinesBiotricity (OTCMKTS:BTCY) Stock Price Down 4.2%September 20, 2024 | americanbankingnews.comBiotricity, Inc.: Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI CloudJuly 22, 2024 | finanznachrichten.deHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.September 27, 2024 | Monument Traders Alliance (Ad)Biotricity launches cardiac monitoring pilot with hospital groupApril 20, 2024 | investing.comAre Medical Stocks Lagging HCA Healthcare (HCA) This Year?March 8, 2024 | finance.yahoo.comBiotricity Inc BTCYFebruary 22, 2024 | morningstar.comBiotricity Stock (NASDAQ:BTCY) Earnings Dates and Earning CallsFebruary 22, 2024 | benzinga.comBiotricity's Earnings OutlookFebruary 19, 2024 | benzinga.comSee More Headlines BTCY Stock Analysis - Frequently Asked Questions How have BTCY shares performed this year? Biotricity's stock was trading at $1.15 at the beginning of the year. Since then, BTCY stock has decreased by 78.3% and is now trading at $0.25. View the best growth stocks for 2024 here. How were Biotricity's earnings last quarter? Biotricity, Inc. (OTCMKTS:BTCY) announced its earnings results on Monday, August, 19th. The company reported ($0.49) earnings per share (EPS) for the quarter. The business had revenue of $3.20 million for the quarter. When did Biotricity's stock split? Shares of Biotricity reverse split on Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. How do I buy shares of Biotricity? Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Biotricity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF) and BioLineRx (BLRX). Company Calendar Last Earnings8/19/2024Today9/27/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryMedical Equipment Current SymbolOTCMKTS:BTCY CUSIPN/A CIK1630113 Webwww.biotricity.com Phone(650) 832-1626FaxN/AEmployees40Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,660,000.00 Net Margins-163.11% Pretax Margin-163.11% Return on EquityN/A Return on Assets-252.90% Debt Debt-to-Equity RatioN/A Current Ratio0.29 Quick Ratio0.14 Sales & Book Value Annual Sales$12.06 million Price / Sales0.50 Cash FlowN/A Price / Cash FlowN/A Book Value($2.67) per share Price / Book-0.10Miscellaneous Outstanding Shares21,645,000Free Float6,963,000Market Cap$6.00 million OptionableNot Optionable Beta1.35 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report This page (OTCMKTS:BTCY) was last updated on 9/27/2024 by MarketBeat.com Staff From Our PartnersThe Bible Says it Clear As DayIt came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This pa...Prosperity Research | Sponsored10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredPrepare for an election day stock surpriseDuring his 50 years on Wall Street, legendary stockpicker Marc Chaikin traded through 13 presidential election...Chaikin Analytics | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredFed Triggers Boom: Buy this Play on Elon’s New AIHave you seen Elon Musk's new invention? I was already very bullish on this new type of AI. And now that...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.